Yasunori Nio, Mitsugi Ookawara, Midori Yamasaki, Guido Hanauer, Kimio Tohyama, Sachio Shibata, Tomoya Sano, Fumi Shimizu, Hisashi Anayama, Masatoshi Hazama, Takanori Matsuo
Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD). Hypertension increases kidney stress, which deteriorates function, and leads to peripheral renal vascular resistance. Long-term hypoperfusion promotes interstitial fibrosis and glomerular sclerosis, resulting in nephrosclerosis. Although hypertension and DN are frequent ESRD complications, relevant animal models remain unavailable. We generated a deoxycorticosterone acetate (DOCA)-salt hypertensive uni-nephrectomized (UNx) KKAy mouse model demonstrating hypertension, hyperglycemia, cardiac hypertrophy, kidney failure, increased urinary albumin creatinine ratio (UACR), and increased renal PDE4D and cardiac PDE5A mRNA levels...
November 2020: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology